MC-DOXHZN hydrochloride is an albumin-binding prodrug of the chemotherapeutic agent Doxorubicin. Upon administration, the prodrug leverages albumin for targeted delivery, where it is activated to release Doxorubicin, a topoisomerase II inhibitor that intercalates DNA. This mechanism is utilized in cancer research for studying improved drug delivery and efficacy in both in vitro and in vivo models.